NEW YORK / LONDON (IT BOLTWISE) – Pfizer shares rose slightly in price on Monday evening in New York. Analyst forecasts point to a positive move as the stock recovers from its 52-week low. The latest quarterly figures and the expected profit distribution are the focus of interest.
Today’s daily deals at Amazon! ˗ˋˏ$ˎˊ˗
Pfizer shares rose slightly by 0.7 percent in the New York trading session on Monday evening, reaching a price of USD 24.68. The daily high was $24.73 while trading started at $24.55. In total, over two million Pfizer shares were traded in New York, indicating keen interest from investors.
Last year, the stock reached its 52-week high of $29.36 on October 19, 2024. To reach this high again, the stock would have to gain 18.99 percent. The price has recovered significantly since the 52-week low of $20.92 and is currently 17.98 percent higher. This development shows investors’ confidence in Pfizer’s long-term stability.
Analysts forecast earnings of $3.05 per share in 2025, which represents a positive development compared to previous years. In 2024, $1.69 was distributed to shareholders and a distribution of $1.70 is expected this year. These numbers underscore the company’s financial health and its ability to provide stable returns to shareholders.
The most recent quarterly numbers, released on August 5, 2025, show EPS of $0.51, a significant improvement from the year-ago quarter’s EPS of $0.01. Sales rose 10.31 percent to $14.65 billion compared to the same quarter last year. These positive results could further boost the stock, especially if the numbers expected for November 4, 2025 are also convincing.
In the context of current market developments, Pfizer remains an important player in the S&P 500 and the stock could benefit from further positive news. Experts see the stable dividend policy and the solid quarterly figures as a reason for optimism. BioNTech’s acquisition of CureVac and developments at Novo Nordisk could also impact the market and change the dynamics of the industry.
*Order an Amazon credit card with no annual fee with a credit limit of 2,000 euros! a‿z
Bestseller No. 1 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 2 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 3 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 4 ᵃ⤻ᶻ “KI Gadgets”
Bestseller No. 5 ᵃ⤻ᶻ “KI Gadgets”
Please send any additions and information to the editorial team by email to de-info[at]it-boltwise.de. Since we cannot rule out AI hallucinations, which rarely occur with AI-generated news and content, we ask you to contact us via email and inform us in the event of false statements or misinformation. Please don’t forget to include the article headline in the email: “Pfizer share: price gains and analyst forecasts in focus”.